# FDA Inspection 1121188 - Lupin Ltd. - February 14, 2020

Source: https://www.keypedia.com/records/fda_inspections/lupin-ltd/c6d4f7de-1152-43af-a8fc-cf09aaad8948
Source feed: FDA_Inspections

> FDA Inspection 1121188 for Lupin Ltd. on February 14, 2020. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1121188
- Company Name: Lupin Ltd.
- Inspection Date: 2020-02-14
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1280668 - 2025-09-05](https://www.keypedia.com/records/fda_inspections/lupin-ltd/0aec7ac9-3de1-4946-b768-6123a636ed4a)
- [FDA Inspection 1235550 - 2024-03-15](https://www.keypedia.com/records/fda_inspections/lupin-ltd/f4abd996-7c86-43f6-9f28-c214fcdc2bdd)
- [FDA Inspection 919852 - 2015-04-03](https://www.keypedia.com/records/fda_inspections/lupin-ltd/8ce1a427-1a6c-4832-8f38-15a864edab4d)
- [FDA Inspection 793847 - 2012-07-27](https://www.keypedia.com/records/fda_inspections/lupin-ltd/01faf1ed-595e-4304-a7a9-c187546c949b)
- [FDA Inspection 636963 - 2009-11-05](https://www.keypedia.com/records/fda_inspections/lupin-ltd/8889d219-a7b4-4307-9f32-f6729665046d)

Company: https://www.keypedia.com/companies/lupin-ltd/1c54bcbf-9d6e-4778-ba85-8d80e3806b2e

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c